Back to search

Article

PCSK9 and breast cancer survival: a Mendelian Randomization study

2025-10-05

Abstract excerpt

<h4>Background</h4> Proprotein convertase subtilisin/kexin type 9 (PCSK9) is well known for its causal effects on the lipid metabolism. A recent study identified an association between rs562556 within PCSK9 and breast cancer survival (BCS). It was suggested that PCSK9 inhibition might allow for early intervention strategies to prevent metastasizing breast cancer. Here, we attempt to replicate these findings by us...

Topics

Open a Topic to create a Post that cites this publication.

Identifiers and source

Literature Corpus work
18333db6-42d1-5472-92f9-469fe8c6a24d
DOI
10.1101/2025.10.03.25337270
Open publication

Related research

Semantic proximity does not establish scientific evidence.

Click a neighbor to travelStep 1 · 12 closest
Interactive article relationship graphSelect a related publication card to move it into the centre and load its closest explainable connections. Solid lines are source-backed structured connections. Dashed lines are semantic discovery signals and are not scientific evidence.
PCSK9 and breast cancer survival: a Mendelian Randomization studyDOI 10.1101/2025.10.03.25337270
Select a neighboring publication to make it the new centre.